Non Hodgkin Lymphoma Incidence and Mortality by Year, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 1,880 11.1 10.6-11.7 959 13.4 12.5-14.3 921 9.6 8.9-10.2 1,040 6.2 5.8-6.6 558 8.0 7.3-8.8 482 5.0 4.5-5.5
1977 1,938 11.3 10.8-11.9 983 13.5 12.6-14.4 955 9.8 9.2-10.4 1,043 6.2 5.8-6.6 509 7.2 6.5-7.8 534 5.4 5.0-5.9
1978 2,086 12.2 11.7-12.8 1,090 14.7 13.8-15.7 996 10.3 9.6-10.9 1,058 6.3 5.9-6.7 553 7.9 7.2-8.6 505 5.1 4.7-5.6
1979 2,006 11.9 11.4-12.4 987 13.8 13.0-14.8 1,019 10.4 9.8-11.1 1,076 6.4 6.1-6.9 565 8.1 7.4-8.8 511 5.2 4.8-5.7
1980 2,188 12.8 12.3-13.4 1,108 15.1 14.2-16.1 1,080 11.0 10.3-11.7 1,100 6.4 6.1-6.8 550 7.6 7.0-8.3 550 5.5 5.1-6.0
1981 2,187 12.7 12.2-13.3 1,069 14.7 13.8-15.7 1,118 11.2 10.6-11.9 1,102 6.4 6.1-6.8 543 7.7 7.1-8.4 559 5.5 5.1-6.0
1982 2,325 13.5 12.9-14.0 1,155 15.7 14.8-16.7 1,170 11.7 11.1-12.5 1,124 6.6 6.2-7.0 561 8.1 7.4-8.8 563 5.6 5.1-6.0
1983 2,438 14.0 13.5-14.6 1,224 16.7 15.7-17.7 1,214 12.0 11.3-12.7 1,219 7.1 6.7-7.5 625 8.7 8.0-9.5 594 5.9 5.4-6.4
1984 2,513 14.5 13.9-15.1 1,296 17.9 16.9-19.0 1,217 12.0 11.3-12.7 1,178 6.8 6.4-7.2 628 9.0 8.2-9.7 550 5.3 4.9-5.8
1985 2,724 15.6 15.0-16.2 1,449 19.6 18.5-20.6 1,275 12.5 11.8-13.2 1,319 7.6 7.2-8.0 693 9.6 8.9-10.4 626 6.1 5.6-6.6
1986 2,857 16.2 15.6-16.8 1,523 20.3 19.3-21.4 1,334 13.0 12.3-13.8 1,312 7.5 7.1-8.0 719 10.1 9.3-10.9 593 5.7 5.2-6.2
1987 2,843 16.1 15.5-16.7 1,537 20.6 19.5-21.6 1,306 12.6 12.0-13.4 1,309 7.5 7.0-7.9 661 9.1 8.4-9.8 648 6.2 5.7-6.7
1988 2,878 16.3 15.7-16.9 1,525 20.1 19.1-21.2 1,353 13.3 12.6-14.1 1,394 8.0 7.5-8.4 714 10.0 9.2-10.8 680 6.5 6.0-7.0
1989 3,022 17.1 16.5-17.7 1,656 21.6 20.6-22.7 1,366 13.4 12.7-14.2 1,388 7.9 7.4-8.3 763 10.5 9.8-11.3 625 5.9 5.5-6.4
1990 3,281 18.4 17.7-19.0 1,820 23.5 22.4-24.7 1,461 14.1 13.4-14.9 1,441 8.1 7.7-8.6 733 10.1 9.4-10.9 708 6.7 6.2-7.2
1991 3,412 19.0 18.4-19.7 1,860 24.4 23.2-25.5 1,552 14.9 14.2-15.7 1,444 8.1 7.7-8.5 768 10.5 9.7-11.2 676 6.3 5.8-6.8
1992 3,363 18.6 18.0-19.3 1,824 23.3 22.2-24.4 1,539 14.8 14.1-15.6 1,517 8.4 8.0-8.9 777 10.6 9.9-11.4 740 6.9 6.4-7.4
1993 3,462 19.1 18.4-19.7 1,920 24.2 23.1-25.3 1,542 14.8 14.1-15.6 1,429 7.8 7.4-8.3 728 9.7 9.0-10.5 701 6.4 6.0-6.9
1994 3,806 20.8 20.1-21.5 2,124 26.6 25.4-27.8 1,682 16.0 15.2-16.8 1,565 8.6 8.1-9.0 801 10.7 10.0-11.5 764 7.0 6.5-7.5
1995 3,695 20.1 19.5-20.8 2,022 25.4 24.3-26.5 1,673 15.8 15.1-16.6 1,554 8.5 8.1-8.9 811 10.9 10.1-11.7 743 6.8 6.3-7.3
1996 3,877 20.9 20.3-21.6 2,090 26.1 25.0-27.3 1,787 16.8 16.1-17.7 1,581 8.6 8.1-9.0 816 11.0 10.2-11.7 765 6.9 6.5-7.5
1997 3,877 20.8 20.1-21.4 2,031 25.2 24.1-26.4 1,846 17.2 16.5-18.0 1,624 8.7 8.3-9.1 824 10.7 10.0-11.5 800 7.2 6.7-7.7
1998 3,857 20.5 19.8-21.1 2,011 24.6 23.5-25.7 1,846 17.2 16.4-18.0 1,552 8.2 7.8-8.6 747 9.5 8.8-10.2 805 7.2 6.7-7.7
1999 3,943 20.6 20.0-21.3 2,004 24.3 23.3-25.4 1,939 17.9 17.1-18.7 1,489 7.8 7.4-8.2 739 9.5 8.9-10.3 750 6.6 6.2-7.1
2000 3,907 20.2 19.6-20.8 2,002 23.9 22.9-25.0 1,905 17.3 16.5-18.1 1,526 7.8 7.5-8.3 768 9.7 9.0-10.4 758 6.6 6.1-7.1
2001 3,923 20.1 19.4-20.7 2,046 24.4 23.3-25.4 1,877 16.8 16.1-17.6 1,444 7.3 7.0-7.7 785 9.7 9.0-10.4 659 5.6 5.1-6.0
2002 3,983 20.2 19.5-20.8 2,141 25.0 23.9-26.1 1,842 16.4 15.7-17.2 1,406 7.1 6.7-7.5 761 9.3 8.7-10.0 645 5.5 5.1-5.9
2003 4,225 21.2 20.5-21.8 2,142 24.7 23.7-25.8 2,083 18.4 17.6-19.2 1,323 6.6 6.2-6.9 671 8.2 7.6-8.8 652 5.4 5.0-5.9
2004 4,199 20.9 20.3-21.5 2,223 25.5 24.4-26.6 1,976 17.4 16.7-18.2 1,303 6.4 6.1-6.8 649 7.8 7.2-8.5 654 5.4 5.0-5.8
2005 4,391 21.7 21.0-22.3 2,298 26.0 24.9-27.1 2,093 18.3 17.5-19.1 1,272 6.2 5.9-6.5 667 8.0 7.4-8.6 605 5.0 4.6-5.4
2006 4,469 21.9 21.3-22.6 2,351 26.4 25.3-27.5 2,118 18.3 17.6-19.2 1,360 6.6 6.3-7.0 692 8.1 7.5-8.8 668 5.4 5.0-5.9
2007 4,481 21.7 21.1-22.4 2,392 26.6 25.5-27.7 2,089 18.0 17.3-18.8 1,262 6.0 5.7-6.4 677 7.8 7.2-8.4 585 4.8 4.4-5.2
2008 4,610 22.1 21.5-22.8 2,466 27.0 25.9-28.1 2,144 18.4 17.6-19.2 1,281 6.1 5.7-6.4 678 7.8 7.2-8.4 603 4.9 4.5-5.3
2009 4,759 22.6 21.9-23.2 2,503 27.1 26.0-28.2 2,256 19.1 18.3-20.0 1,250 5.8 5.5-6.2 689 7.7 7.1-8.3 561 4.5 4.1-4.9
2010 4,679 21.8 21.2-22.4 2,478 26.3 25.3-27.4 2,201 18.2 17.4-19.0 1,264 5.8 5.5-6.1 661 7.3 6.8-7.9 603 4.7 4.4-5.2
2011 4,775 22.0 21.4-22.6 2,574 26.9 25.8-27.9 2,201 18.2 17.4-19.0 1,270 5.8 5.5-6.1 676 7.3 6.8-7.9 594 4.6 4.3-5.0
2012 4,740 21.5 20.9-22.1 2,553 26.3 25.3-27.3 2,187 17.8 17.1-18.6 1,236 5.5 5.2-5.8 675 7.3 6.7-7.9 561 4.2 3.9-4.6
2013 4,889 21.9 21.3-22.5 2,641 26.8 25.8-27.9 2,248 18.0 17.2-18.8 1,179 5.2 4.9-5.5 635 6.7 6.2-7.3 544 4.1 3.7-4.4
2014 5,006 22.0 21.4-22.6 2,732 27.3 26.2-28.3 2,274 17.9 17.1-18.7 1,236 5.3 5.0-5.6 677 7.0 6.5-7.6 559 4.0 3.7-4.4
2015 5,013 21.8 21.2-22.4 2,727 26.6 25.6-27.7 2,286 18.0 17.3-18.8 1,182 5.1 4.8-5.4 662 6.8 6.3-7.3 520 3.8 3.5-4.2
2016 5,116 21.9 21.3-22.5 2,703 25.9 24.9-26.9 2,413 18.8 18.0-19.6 1,251 5.2 4.9-5.5 675 6.7 6.2-7.2 576 4.1 3.8-4.5
2017 5,118 21.7 21.1-22.3 2,759 26.2 25.2-27.2 2,359 18.2 17.4-19.0 1,274 5.2 4.9-5.5 713 6.9 6.4-7.5 561 3.9 3.6-4.3
2018 5,020 21.1 20.5-21.7 2,654 24.9 23.9-25.9 2,366 18.2 17.4-19.0 1,112 4.5 4.2-4.7 636 6.1 5.6-6.6 476 3.3 3.0-3.6
2019 5,193 21.4 20.8-22.0 2,830 26.0 25.1-27.0 2,363 17.8 17.1-18.6 1,157 4.6 4.3-4.9 647 6.0 5.6-6.5 510 3.5 3.2-3.8
2020 4,583 18.8 18.3-19.4 2,462 22.5 21.6-23.4 2,121 15.9 15.2-16.7 1,064 4.2 3.9-4.4 581 5.4 4.9-5.8 483 3.3 3.0-3.6

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.